• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医用大麻:患者特征、获取途径和使用原因。

Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.

机构信息

University of British Columbia, 3333 University Way, Kelowna, BC V1V1V7, Canada.

1814B Edgehill Court, Kelowna, BC V1V 1R7, Canada.

出版信息

Int J Drug Policy. 2013 Nov;24(6):511-6. doi: 10.1016/j.drugpo.2013.08.010. Epub 2013 Sep 9.

DOI:10.1016/j.drugpo.2013.08.010
PMID:24095000
Abstract

BACKGROUND

The authorized and unauthorized use of cannabis for therapeutic purposes (CTP) has increased dramatically in recent years, and physicians have called for further research to better clarify the parameters of effective and appropriate use. We report findings from a large cross-sectional study of the use of CTP in Canada and compare use across medical conditions and across authorized and unauthorized users.

METHODS

We examined cannabis use history, medical conditions and symptoms, patterns of current use of CTP, modes of access and perceived effectiveness among 628 self-selected Canadians consumers of CTP. Participants were recruited from medical cannabis dispensaries and from organizations that assist users of CTP.

RESULTS

Patients reported using cannabis to treat multiple symptoms, with sleep, pain, and anxiety being the most common. Cannabis was perceived to provide effective symptoms relief across medical conditions. Patterns of use were also consistent across medical conditions. Notable differences were observed with regard to modes of access.

CONCLUSION

Across medical conditions respondents reported using cannabis to effectively address diverse symptoms. Results indicate a substantial disconnect between the therapeutic use of cannabis and research on the risks and benefits of such use; particularly with regard to the anxiolytic and sedative use of cannabis. Authorized and unauthorized users exhibited few meaningful differences with regard to medical conditions and patterns of use, but faced substantial differences regarding access.

摘要

背景

近年来,出于治疗目的(CTP)而合法和非法使用大麻的情况急剧增加,医生呼吁进行更多研究,以更好地阐明有效和适当使用的参数。我们报告了一项对加拿大 CTP 使用情况的大型横断面研究结果,并比较了不同医疗条件下以及合法和非法使用者之间的使用情况。

方法

我们调查了 628 名自我选择的 CTP 使用者的大麻使用史、医疗状况和症状、当前 CTP 使用模式、获取途径和感知效果。参与者是从医用大麻药房和协助 CTP 用户的组织中招募的。

结果

患者报告说,大麻可用于治疗多种症状,最常见的是睡眠、疼痛和焦虑。大麻被认为可以有效缓解各种医疗状况下的症状。使用模式在不同的医疗条件下也保持一致。在获取途径方面观察到了显著差异。

结论

受访者报告说,在各种医疗条件下,大麻被用于有效缓解多种症状。结果表明,大麻的治疗用途与关于此类用途的风险和益处的研究之间存在很大的脱节;特别是在大麻的抗焦虑和镇静作用方面。在医疗条件和使用模式方面,合法和非法使用者之间几乎没有明显差异,但在获取途径方面却存在很大差异。

相似文献

1
Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.医用大麻:患者特征、获取途径和使用原因。
Int J Drug Policy. 2013 Nov;24(6):511-6. doi: 10.1016/j.drugpo.2013.08.010. Epub 2013 Sep 9.
2
Barriers to access for Canadians who use cannabis for therapeutic purposes.为治疗目的使用大麻的加拿大人面临的准入障碍。
Int J Drug Policy. 2014 Jul;25(4):691-9. doi: 10.1016/j.drugpo.2014.02.009. Epub 2014 Feb 28.
3
Are dispensaries indispensable? Patient experiences of access to cannabis from medical cannabis dispensaries in Canada. dispensaries 是否不可或缺?加拿大从医用大麻药房获取大麻的患者体验。
Int J Drug Policy. 2017 Sep;47:1-8. doi: 10.1016/j.drugpo.2017.05.046. Epub 2017 Jun 28.
4
Growing medicine: small-scale cannabis cultivation for medical purposes in six different countries.种植药用大麻:六个不同国家小规模医用大麻种植。
Int J Drug Policy. 2015 Mar;26(3):250-6. doi: 10.1016/j.drugpo.2014.07.005. Epub 2014 Jul 21.
5
Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users.医用大麻使用者自我报告的大麻使用特征、模式及效用。
Am J Drug Alcohol Abuse. 2014 Jan;40(1):23-30. doi: 10.3109/00952990.2013.821477. Epub 2013 Nov 8.
6
Barriers to access to medical cannabis for Canadians living with HIV/AIDS.加拿大艾滋病毒/艾滋病患者获取医用大麻的障碍。
AIDS Care. 2007 Apr;19(4):500-6. doi: 10.1080/09540120701207833.
7
Medical cannabis: US researchers battle for access to the plant.医用大麻:美国研究人员为获取该植物而斗争。
BMJ. 2014 Nov 21;349:g6997. doi: 10.1136/bmj.g6997.
8
Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients.医用大麻的获取、使用以及对处方阿片类药物和其他物质的替代:对合法医用大麻患者的一项调查
Int J Drug Policy. 2017 Apr;42:30-35. doi: 10.1016/j.drugpo.2017.01.011. Epub 2017 Feb 9.
9
Mental Health and Medical Cannabis Use among Youth and Young Adults in Canada.加拿大青少年和年轻成年人的心理健康与医用大麻使用。
Subst Use Misuse. 2020;55(4):582-589. doi: 10.1080/10826084.2019.1691594. Epub 2019 Nov 20.
10
Cannabis Enthusiasts' Knowledge of Medical Treatment Effectiveness and Increased Risks From Cannabis Use.大麻爱好者对医疗效果的了解以及增加的大麻使用风险。
Am J Health Promot. 2020 May;34(4):436-439. doi: 10.1177/0890117119899218. Epub 2020 Jan 9.

引用本文的文献

1
Clinical and Cognitive Improvement Following Treatment with a Hemp-Derived, Full-Spectrum, High-Cannabidiol Product in Patients with Anxiety: An Open-Label Pilot Study.焦虑症患者使用大麻衍生的全谱、高大麻二酚产品治疗后的临床和认知改善:一项开放标签的试点研究。
Biomedicines. 2025 Aug 1;13(8):1874. doi: 10.3390/biomedicines13081874.
2
"Becoming a Medical Cannabis User" Revisited: Understanding the Role of Low-Threshold Access Points in British Columbia, Canada.再谈“成为医用大麻使用者”:理解加拿大不列颠哥伦比亚省低门槛接入点的作用
Contemp Drug Probl. 2025 Jan 22;52(3):344-367. doi: 10.1177/00914509241312872. eCollection 2025 Sep.
3
Willingness to use a drug checking service for cannabis and cannabis-based products: results from an online survey of people who regularly use cannabis in France.
使用大麻及大麻制品药物检测服务的意愿:法国定期使用大麻人群在线调查结果
Harm Reduct J. 2025 Jul 19;22(1):126. doi: 10.1186/s12954-025-01274-0.
4
Conceptualizing 'cannabis harm reduction': lessons learned from cannabis compassion clubs and medical dispensaries in British Columbia (Canada).“大麻危害减少”的概念化:从加拿大不列颠哥伦比亚省的大麻同情俱乐部和医用大麻药房中吸取的经验教训。
Harm Reduct J. 2025 Apr 30;22(1):70. doi: 10.1186/s12954-025-01199-8.
5
Patients' Experiences Discussing Psychedelics for Therapeutic Purposes with Physicians and Other Health Care Providers.患者与医生及其他医疗服务提供者讨论将迷幻剂用于治疗目的的经历。
Psychedelic Med (New Rochelle). 2024 Sep 4;2(3):161-165. doi: 10.1089/psymed.2023.0060. eCollection 2024 Sep.
6
Role of Cannabis in the Management of Chronic Non-Cancer Pain: A Narrative Review.大麻在慢性非癌性疼痛管理中的作用:一项叙述性综述。
Clin Pract. 2025 Jan 13;15(1):16. doi: 10.3390/clinpract15010016.
7
Examining the Relationship Between Cannabis Use and Mood, Anxiety, and Psychotic Symptoms in Psychiatric Patients with Severe Concurrent Mental Health and Substance Use Disorders Before and After Recreational Cannabis Legalization in Canada.研究加拿大娱乐用大麻合法化前后,患有严重并发精神健康和物质使用障碍的精神病患者中,大麻使用与情绪、焦虑及精神病症状之间的关系。
Cannabis. 2024 Dec 12;7(3):90-105. doi: 10.26828/cannabis/2024/000258. eCollection 2024.
8
Medical Marijuana Documentation Practices in Patient Electronic Health Records: Retrospective Observational Study Using Smart Data Elements and a Review of Medical Records.患者电子健康记录中的医用大麻记录实践:使用智能数据元素的回顾性观察研究及病历审查
JMIR Form Res. 2024 Dec 23;8:e65957. doi: 10.2196/65957.
9
Psychosis associated with cannabis withdrawal: systematic review and case series.与大麻戒断相关的精神病:系统评价与病例系列
Br J Psychiatry. 2024 Dec 3:1-12. doi: 10.1192/bjp.2024.175.
10
Cannabis Consumption Among Adults Aged 55-65 in Canada, 2018-2021.2018 - 2021年加拿大55 - 65岁成年人的大麻消费情况
J Drug Issues. 2025 Jan;55(1):33-49. doi: 10.1177/00220426231190022. Epub 2023 Jul 19.